Summary of Significant Accounting Policies - Narrative (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2020 USD ($) FDA_drug
Accounting Policies [Abstract]
Number of products with FDA approval | FDA_drug	3
Disposal Group, Disposed of by Sale, Not Discontinued Operations | The Business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Initial cash consideration	$ 14,500
Additional consideration paid in monthly installments	$ 27,500
Payment installment term (in months)	10 months
Aggregate consideration	$ 42,000